Development of Newborn Screening for Pompe Disease
Open Access
- 24 January 2020
- journal article
- editorial
- Published by MDPI AG in International Journal of Neonatal Screening
- Vol. 6 (1), 5
- https://doi.org/10.3390/ijns6010005
Abstract
Pompe disease is an inborn error of lysosomal degradation of glycogenKeywords
This publication has 12 references indexed in Scilit:
- Algorithm for Pompe disease newborn screening: Results from the Taiwan screening programMolecular Genetics and Metabolism, 2012
- Later-Onset Pompe Disease: Early Detection and Early Treatment Initiation Enabled by Newborn ScreeningThe Journal of Pediatrics, 2011
- Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot programMolecular Genetics and Metabolism, 2010
- Pompe Disease in Infants: Improving the Prognosis by Newborn Screening and Early TreatmentPEDIATRICS, 2009
- Early Detection of Pompe Disease by Newborn Screening Is Feasible: Results From the Taiwan Screening ProgramPEDIATRICS, 2008
- Newborn Screening for Pompe Disease: Synthesis of the Evidence and Development of Screening RecommendationsPEDIATRICS, 2007
- Recombinant human acid α-glucosidaseNeurology, 2007
- Brain Development in Infantile-Onset Pompe Disease Treated by Enzyme Replacement TherapyPediatric Research, 2006
- Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn ScreeningClinical Chemistry, 2004
- Tay-Sachs and Sandhoff diseases: enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnoses in newborn-screening cardsClinica Chimica Acta; International Journal of Clinical Chemistry, 2002